Matthew Ros
2019
Compensation breakdown
Non-Equity Incentive Plan | $199,861 |
---|---|
Option Awards | $899,137 |
Salary | $432,600 |
Stock Awards | $538,793 |
Other | $11,598 |
Total | $2,081,989 |
Ros received $899.1K in option awards, accounting for 43% of the total pay in 2019.
Ros also received $199.9K in non-equity incentive plan, $432.6K in salary, $538.8K in stock awards and $11.6K in other compensation.
Rankings
In 2019, Matthew Ros' compensation ranked 5,724th out of 13,971 executives tracked by ExecPay. In other words, Ros earned more than 59.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,724 | 59th |
Manufacturing | 2,143 | 62nd |
Chemicals And Allied Products | 772 | 65th |
Drugs | 649 | 66th |
Pharmaceutical Preparations | 476 | 66th |
Pay ratio
Matthew Ros' Pay | $2,081,989 |
---|---|
Median Employee's Pay | $302,723 |
Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Matthew Ros was $2,081,989.
The annual total compensation of the median employee at Epizyme was $302,723.
The ratio of Matthew Ros' pay to the pay of median employee was therefore 7 to one.
Ros' colleagues
We found four more compensation records of executives who worked with Matthew Ros at Epizyme in 2019.